Merit Medical Systems, Inc. (NASDAQ:MMSI) released its earnings results on Wednesday. The medical instruments supplier reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.07, Bloomberg Earnings reports. Merit Medical Systems had a return on equity of 9.36% and a net margin of 4.80%. The firm had revenue of $186.50 million for the quarter, compared to analyst estimates of $181.46 million. During the same quarter in the prior year, the firm posted $0.26 earnings per share. The company’s quarterly revenue was up 23.4% on a year-over-year basis. Merit Medical Systems updated its FY17 guidance to $1.23-$1.28 EPS.

Merit Medical Systems (NASDAQ:MMSI) traded down 2.70% during midday trading on Wednesday, hitting $37.80. The stock had a trading volume of 333,607 shares. Merit Medical Systems has a 52 week low of $20.70 and a 52 week high of $40.00. The company’s 50 day moving average price is $37.17 and its 200-day moving average price is $31.77. The stock has a market capitalization of $1.89 billion, a price-to-earnings ratio of 56.17 and a beta of 1.25.

Several research firms have weighed in on MMSI. Bank of America Corporation began coverage on Merit Medical Systems in a research note on Thursday, July 20th. They issued a “buy” rating and a $44.00 target price on the stock. Sidoti reissued a “buy” rating and issued a $46.00 target price (up previously from $41.00) on shares of Merit Medical Systems in a research note on Wednesday, June 28th. Wells Fargo & Company began coverage on Merit Medical Systems in a research note on Wednesday, April 5th. They issued an “outperform” rating and a $31.70 target price on the stock. BidaskClub raised Merit Medical Systems from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, June 27th. Finally, Canaccord Genuity reissued a “buy” rating and issued a $37.00 target price on shares of Merit Medical Systems in a research note on Friday, April 28th. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $37.52.

TRADEMARK VIOLATION WARNING: “Merit Medical Systems, Inc. (MMSI) Issues Quarterly Earnings Results” was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this news story can be read at https://www.americanbankingnews.com/2017/07/26/merit-medical-systems-inc-mmsi-issues-quarterly-earnings-results.html.

In related news, insider Richard W. Edelman sold 20,000 shares of the stock in a transaction dated Friday, June 30th. The shares were sold at an average price of $37.62, for a total value of $752,400.00. Following the sale, the insider now directly owns 35,000 shares of the company’s stock, valued at approximately $1,316,700. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Michael E. Stillabower sold 17,110 shares of the stock in a transaction dated Friday, May 19th. The stock was sold at an average price of $33.71, for a total transaction of $576,778.10. Following the completion of the sale, the director now directly owns 52,778 shares in the company, valued at $1,779,146.38. The disclosure for this sale can be found here. Insiders sold a total of 82,944 shares of company stock worth $2,944,127 over the last three months. 5.60% of the stock is currently owned by corporate insiders.

About Merit Medical Systems

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Earnings History for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.